ZA997227B - Process and intermediates for growth hormone secretagogues. - Google Patents

Process and intermediates for growth hormone secretagogues.

Info

Publication number
ZA997227B
ZA997227B ZA9907227A ZA997227A ZA997227B ZA 997227 B ZA997227 B ZA 997227B ZA 9907227 A ZA9907227 A ZA 9907227A ZA 997227 A ZA997227 A ZA 997227A ZA 997227 B ZA997227 B ZA 997227B
Authority
ZA
South Africa
Prior art keywords
intermediates
growth hormone
hormone secretagogues
secretagogues
growth
Prior art date
Application number
ZA9907227A
Other languages
English (en)
Inventor
Charles Kwok-Fung Chiu
David Andrew Griffith
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA997227B publication Critical patent/ZA997227B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D247/00Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9907227A 1998-11-23 1999-11-22 Process and intermediates for growth hormone secretagogues. ZA997227B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10952498P 1998-11-23 1998-11-23

Publications (1)

Publication Number Publication Date
ZA997227B true ZA997227B (en) 2001-05-22

Family

ID=22328134

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9907227A ZA997227B (en) 1998-11-23 1999-11-22 Process and intermediates for growth hormone secretagogues.

Country Status (20)

Country Link
US (4) US6297380B1 (fr)
EP (1) EP1004583B1 (fr)
JP (2) JP3488155B2 (fr)
KR (1) KR20000035568A (fr)
CN (1) CN1255498A (fr)
AR (1) AR019498A1 (fr)
AT (1) ATE274517T1 (fr)
AU (1) AU5958499A (fr)
BR (1) BR9905732A (fr)
CA (1) CA2290252C (fr)
DE (1) DE69919663T2 (fr)
DK (1) DK1004583T3 (fr)
ES (1) ES2226297T3 (fr)
HU (1) HUP9904384A3 (fr)
ID (1) ID23852A (fr)
IL (1) IL133043A0 (fr)
PL (1) PL336710A1 (fr)
PT (1) PT1004583E (fr)
TR (1) TR199902879A2 (fr)
ZA (1) ZA997227B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3514774B2 (ja) * 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体
US6297380B1 (en) 1998-11-23 2001-10-02 Pfizer Inc. Process and intermediates for growth hormone secretagogues
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (fr) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
WO2002044181A1 (fr) 2000-12-01 2002-06-06 Bristol-Myers Squibb Company Composes d'hydantoine utiles en tant qu'agents anti-inflammatoires
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1414795A4 (fr) 2001-07-31 2006-03-01 Bristol Myers Squibb Co Modulateurs bicycliques de la fonction du recepteur androgene
PL206962B1 (pl) * 2001-12-19 2010-10-29 Bristol Myers Squibb Co Związek heterocykliczny o budowie skondensowanej
US7405234B2 (en) 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
EP1567487A4 (fr) 2002-11-15 2005-11-16 Bristol Myers Squibb Co Modulateurs lies a prolyl uree a chaine ouverte de la fonction du recepteur d'androgene
US7820702B2 (en) 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US7625923B2 (en) 2004-03-04 2009-12-01 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
CN103211824B (zh) * 2006-04-13 2017-04-19 纽若泰克制药株式会社 用于治疗或预防退行性和炎症性疾病的药物组合物
EP2039695A4 (fr) 2006-07-11 2010-09-15 Takeda Pharmaceutical Composé hétérocyclique bicycique et son utilisation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746755A (en) 1986-05-06 1988-05-24 The Dow Chemical Company Preparation of hydrantoic acids and hydantoins
DE3643748A1 (de) 1986-12-20 1988-06-30 Hoechst Ag Bicylische imide, verfahren zu ihrer herstellung sowie ihre verwendung im pflanzenschutz
US4868061A (en) 1988-05-19 1989-09-19 The Standard Oil Company Olefinic aryl oxime derivatives of hydantoins
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
GB2324087A (en) * 1997-04-10 1998-10-14 Merck & Co Inc Preparation of (S)-3-Carbethoxy-3-benzylpiperidine
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体
US6358951B1 (en) * 1998-08-21 2002-03-19 Pfizer Inc. Growth hormone secretagogues
US6297380B1 (en) 1998-11-23 2001-10-02 Pfizer Inc. Process and intermediates for growth hormone secretagogues

Also Published As

Publication number Publication date
AU5958499A (en) 2000-05-25
DK1004583T3 (da) 2004-12-13
EP1004583A3 (fr) 2000-06-14
EP1004583B1 (fr) 2004-08-25
HU9904384D0 (en) 2000-01-28
IL133043A0 (en) 2001-03-19
HUP9904384A2 (hu) 2000-08-28
US6603002B2 (en) 2003-08-05
US6465651B2 (en) 2002-10-15
ATE274517T1 (de) 2004-09-15
ID23852A (id) 2000-05-25
JP3488155B2 (ja) 2004-01-19
TR199902879A2 (xx) 2000-06-21
AR019498A1 (es) 2002-02-20
PT1004583E (pt) 2004-12-31
CA2290252A1 (fr) 2000-05-23
BR9905732A (pt) 2001-03-20
JP2000159770A (ja) 2000-06-13
KR20000035568A (ko) 2000-06-26
US6686471B2 (en) 2004-02-03
DE69919663D1 (de) 2004-09-30
EP1004583A2 (fr) 2000-05-31
CA2290252C (fr) 2004-08-24
CN1255498A (zh) 2000-06-07
JP2003012672A (ja) 2003-01-15
DE69919663T2 (de) 2005-09-01
ES2226297T3 (es) 2005-03-16
US20030225280A1 (en) 2003-12-04
US20030088097A1 (en) 2003-05-08
US6297380B1 (en) 2001-10-02
HUP9904384A3 (en) 2002-04-29
US20020010335A1 (en) 2002-01-24
PL336710A1 (en) 2000-06-05

Similar Documents

Publication Publication Date Title
ZA987385B (en) Growth hormone secretagogues.
AU6772996A (en) 2-acylaminopropanamides as growth hormone secretagogues
ZA9811407B (en) Crystalline teriparatide.
MXPA01002538A (es) Fertilizante foliar y metodo para utilizar el mismo.
AU6606601A (en) Growth hormone secretagogues
IL154115A0 (en) Process for the preparation of growth hormone secretagogues
ZA966891B (en) 2-acylaminopropanamines as growth hormone secretagogues.
ZA997227B (en) Process and intermediates for growth hormone secretagogues.
CZ20012118A3 (cs) Způsob výroby 3-alkanoylindolu a 3-alkylindolu
SG118060A1 (en) Process for preparation of pyrazoloÄ4,3-dÜpyrimidin-7-ones and intermediates thereof
HK1041585A1 (en) Receiving terminal, method for controlling and using the same
GB2333521B (en) Nitride crystal growth method
IL144350A0 (en) Growth hormone secretagogues
HUP0101779A3 (en) Process for de-chlorinating and de-fouling waste-oil
ZA9711523B (en) Continuous fermentation process
EP1126854A4 (fr) Benzoazepines et leurs analogues utiles en tant que secretagogues d'hormones de croissance
ZA200000888B (en) Process for preparing growth hormone secretagogues.
ZA979094B (en) Placental-derived prostate growth factors.
EP1112071A4 (fr) Secretagogues d'hormones de croissance
SI1004583T1 (en) Process and hydantoin intermediates for the synthesis of growth hormone secretagogues
HUP9800619A1 (en) Fermentation process
GB2343642B (en) Improved fastening method
HU9900121D0 (en) Process for producing naphthyridones and intermediates
ZA971119B (en) Processes for preparing intermediates.
GB9810681D0 (en) Hormone